Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Vincent K Lam

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Current Opinion in Oncology|January 13, 2018
Master protocols in lung cancer: experience from Lung Master ProtocolVincent K Lam, Vassiliki Papadimitrakopoulou
Advances in Therapy|August 12, 2023
Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain MetastasisGeoffrey Liu, Vincent K Lam
Journal of Thoracic Disease|August 3, 2019
Blood-based tumor mutation burden: continued progress toward personalizing immunotherapy in non-small cell lung cancerVincent K Lam, Jianjun Zhang
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 22, 2025
Corrigendum to 'Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLC' [Journal of Thoracic Oncology Volume 20 Issue 2 (2025) 150-153]Vincent K Lam, Shirish M Gadgeel
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2020
Another Brick in the Wall: Sintilimab Plus Chemotherapy in Advanced Lung CancerVincent K Lam, Patrick M Forde
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLCVincent K Lam, Shirish M Gadgeel
Clinical and Translational Medicine|February 4, 2025
The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancersRonan J Kelly, Valsamo Anagnostou, Vincent K Lam, et al.
Cancers|January 23, 2024
The Evolving Landscape of Neoadjuvant Immunotherapy in Gastroesophageal CancerColum Dennehy, Alisha F Khan, Ali H Zaidi, et al.
Journal of Gastrointestinal Cancer|October 25, 2012
Characteristics of colorectal cancer survival in an urban county hospitalVincent K Lam, An-Ting T Lu, Natalia Kouzminova, et al.
Cancer Discovery|June 3, 2024
Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual DiseaseJessica J Lin, Justin F Gainor, Vincent K Lam, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Current Opinion in Oncology|January 13, 2018
Master protocols in lung cancer: experience from Lung Master ProtocolVincent K Lam, Vassiliki Papadimitrakopoulou
Advances in Therapy|August 12, 2023
Podcast on Lorlatinib as a First-Line Treatment Option for Patients with ALK-Positive Metastatic NSCLC with Brain MetastasisGeoffrey Liu, Vincent K Lam
Journal of Thoracic Disease|August 3, 2019
Blood-based tumor mutation burden: continued progress toward personalizing immunotherapy in non-small cell lung cancerVincent K Lam, Jianjun Zhang
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 22, 2025
Corrigendum to 'Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLC' [Journal of Thoracic Oncology Volume 20 Issue 2 (2025) 150-153]Vincent K Lam, Shirish M Gadgeel
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|September 28, 2020
Another Brick in the Wall: Sintilimab Plus Chemotherapy in Advanced Lung CancerVincent K Lam, Patrick M Forde
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|February 6, 2025
Even With the CROWN Findings, There Remain Multiple First-Line Treatment Options for Patients With Advanced ALK-Positive NSCLCVincent K Lam, Shirish M Gadgeel
Clinical and Translational Medicine|February 4, 2025
The utilisation of ctDNA approaches for residual disease detection during neoadjuvant and perioperative immunotherapy in oesophagogastric cancersRonan J Kelly, Valsamo Anagnostou, Vincent K Lam, et al.
Cancers|January 23, 2024
The Evolving Landscape of Neoadjuvant Immunotherapy in Gastroesophageal CancerColum Dennehy, Alisha F Khan, Ali H Zaidi, et al.
Journal of Gastrointestinal Cancer|October 25, 2012
Characteristics of colorectal cancer survival in an urban county hospitalVincent K Lam, An-Ting T Lu, Natalia Kouzminova, et al.
Cancer Discovery|June 3, 2024
Unlocking the Next Frontier in Precision Oncology: Addressing Drug-Tolerant Residual DiseaseJessica J Lin, Justin F Gainor, Vincent K Lam, et al.
Pageof 6